Results 211 to 220 of about 358,941 (349)
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
Gary Kohanbash +14 more
semanticscholar +1 more source
MMP14 amplifies TGF‐β signaling to create a necroptosis‐heterogeneous landscape that fuels GBM progression. Targeting this axis may disrupt the adaptive mechanisms underlying treatment failure, offering a path to precision therapy for this intractable malignancy.
Haoyu Zhou +7 more
wiley +1 more source
Histopathological grading affects survival in patients with isocitrate dehydrogenase-wildtype gliomas. [PDF]
Hou Z, Liu D, Hou Z, Zhang H, Wang H.
europepmc +1 more source
Anti-Apoptotic and Anti-Oxidant Proteins in Glioblastomas: Immunohistochemical Expression of Beclin and DJ-1 and Its Correlation with Prognosis. [PDF]
Arcidiacono Biagio +11 more
core +1 more source
We investigated two models of mitochondrial dysfunction in podocytes, using two cell culture models: podocytes isolated from mice with Oma1 deletion (Oma1del) and mouse podocytes modified with an inducible knockdown of PHB2 (Phb2kd). OMA1 deficiency induced a glycolytic shift, enhanced glutamine anaplerosis, and sustained energy homeostasis after ...
Cem Özel +13 more
wiley +1 more source
Enzyme response to thyrotoxicosis and hypothyroidism in human liver and muscle [PDF]
Bachmaier, B. +5 more
core
P12.36.A ISOCITRATE DEHYDROGENASE INHIBITION PRIMES GLIOBLASTOMA CELLS FOR STATIN-INDUCED CELL DEATH [PDF]
Laura Marosits +3 more
openalex +1 more source
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
Biqi Zhang +9 more
semanticscholar +1 more source

